We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+2.25%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$203M
AUM Growth
+$6.95M
Cap. Flow
+$3.45M
Cap. Flow %
1.7%
Top 10 Hldgs %
24.55%
Holding
99
New
4
Increased
34
Reduced
35
Closed
2

Top Buys

Rank Stock Value
1
GIS icon
General Mills
GIS
+$2.77M
2
IBB icon
iShares Biotechnology ETF
IBB
+$356K
3
CL icon
Colgate-Palmolive
CL
+$345K
4
CVS icon
CVS Health
CVS
+$285K
5
GE icon
GE Aerospace
GE
+$272K

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$618K
2
MA icon
Mastercard
MA
+$472K
3
BBH icon
VanEck Biotech ETF
BBH
+$315K
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$228K
5
CLX icon
Clorox
CLX
+$212K

Sector Composition

Rank Sector Weight
1 Technology 14.43%
2 Industrials 13.17%
3 Healthcare 12.14%
4 Financials 10.95%
5 Consumer Staples 10.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OIH icon
51
VanEck Oil Services ETF
OIH
$1.99B
$1.64M 0.81%
3,130
+52
+2% +$27.8K
BBH icon
52
VanEck Biotech ETF
BBH
$409M
$1.43M 0.7%
11,933
-2,670
-18% -$315K
IBB icon
53
iShares Biotechnology ETF
IBB
$9.55B
$1.3M 0.64%
11,844
+3,330
+39% +$356K
IAU icon
54
iShares Gold Trust
IAU
$62.5B
$1.25M 0.62%
52,105
+4,825
+10% +$121K
CVX icon
55
Chevron
CVX
$374B
$1.25M 0.61%
9,872
+280
+3% +$34.8K
JNJ icon
56
Johnson & Johnson
JNJ
$643B
$1.14M 0.56%
9,355
– –
T icon
57
AT&T
T
$169B
$1.09M 0.54%
44,886
+2,233
+5% +$56K
GOOG icon
58
Alphabet (Google) Class C
GOOG
$4.07T
$1.08M 0.53%
19,380
– –
AMJ
59
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$1.08M 0.53%
40,650
-6,430
-14% -$168K
CTAS icon
60
Cintas
CTAS
$86B
$1.02M 0.5%
22,120
– –
JPM icon
61
JPMorgan Chase
JPM
$950B
$992K 0.49%
9,523
+670
+8% +$73.5K
PFE icon
62
Pfizer
PFE
$144B
$825K 0.41%
23,977
+2,716
+13% +$92.8K
DIS icon
63
Walt Disney
DIS
$172B
$774K 0.38%
7,391
– –
SYK icon
64
Stryker
SYK
$133B
$765K 0.38%
4,534
– –
AOR icon
65
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.65B
$692K 0.34%
15,622
+10
+0.1% +$446
DUK icon
66
Duke Energy
DUK
$101B
$621K 0.31%
7,859
-548
-7% -$42.1K
BXP icon
67
Boston Properties
BXP
$11.2B
$608K 0.3%
4,850
– –
NEE icon
68
NextEra Energy
NEE
$186B
$596K 0.29%
14,280
-280
-2% -$11.3K
IBM icon
69
IBM
IBM
$214B
$561K 0.28%
4,203
– –
SYY icon
70
Sysco
SYY
$40.7B
$559K 0.28%
8,190
-430
-5% -$27.5K
PAYX icon
71
Paychex
PAYX
$42.3B
$530K 0.26%
7,755
– –
BA icon
72
Boeing
BA
$175B
$527K 0.26%
1,571
– –
VEU icon
73
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
$517K 0.25%
9,989
-710
-7% -$38.5K
CAT icon
74
Caterpillar
CAT
$387B
$445K 0.22%
3,282
– –
BMY icon
75
Bristol-Myers Squibb
BMY
$130B
$438K 0.22%
7,930
– –
1 2
3
4

Similar funds

SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
TFP
Triune Financial Partners Overland Park, Kansas $421M AUM 22.09% 1-Year Est. Return
CWM
Cordatus Wealth Management Newtown, Pennsylvania $420M AUM 24.63% 1-Year Est. Return
MG
MilWealth Group Milwaukee, Wisconsin $420M AUM 12.37% 1-Year Est. Return
HWMG
Hurlow Wealth Management Group Bloomington, Indiana $420M AUM 16.85% 1-Year Est. Return
AI
ArchPoint Investors Coral Gables, Florida $420M AUM 42.19% 1-Year Est. Return
IMA
Investment Management Associates Greenwood Village, Colorado $420M AUM 11.81% 1-Year Est. Return
GPA
Guidance Point Advisors Wellesley, Massachusetts $422M AUM 16.47% 1-Year Est. Return

Boston Research & Management's Q2 2018 Portfolio in Review

As of Q2 2018, Boston Research & Management held 99 positions worth $203M, up 3.5% from $196M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Boston Research & Management's Q2 2018 filing shows 4 new, 34 increased, 35 reduced and 2 closed positions. Its largest new stake was General Mills: 63,350 shares worth $2.8M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $618K.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Industrials and Healthcare.

  • Boston Research & Management's largest Q2 2018 buy was General Mills: 63,350 shares worth $2.8M.
  • Boston Research & Management added most to iShares Biotechnology ETF in Q2 2018, an estimated $356K increase.
  • Boston Research & Management's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $618K.
  • Boston Research & Management fully exited iShares MSCI EAFE ETF in Q2 2018, selling an estimated $228K.
  • Boston Research & Management's ten largest holdings make up 25% of its $203M portfolio in Q2 2018.
  • Boston Research & Management opened 4 new positions and closed 2 in Q2 2018.
  • Boston Research & Management's portfolio value rose 3.5% quarter-over-quarter to $203M.

Based on Boston Research & Management's 13F filing for Q2 2018, filed 30 Jul 2018.